Xoma transfers perindopril franchise to Symplmed startup
This article was originally published in Scrip
Executive Summary
Xoma has transferred its rights to the hypertension drug perindopril that it licensed from Les Laboratoires Servier in early 2012 to a new firm founded by two of the Berkeley, California-based company's former employees.